Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 7.36
(-0.14%)
CNY 7.36
(-0.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 175.99 Million CNY | -15.18% |
| 2022 | 160.53 Million CNY | -9.87% |
| 2021 | 179.81 Million CNY | 7.08% |
| 2020 | 159.53 Million CNY | -10.79% |
| 2019 | 167.56 Million CNY | 3.91% |
| 2018 | 163.68 Million CNY | -1.89% |
| 2017 | 166.74 Million CNY | 41.63% |
| 2016 | 97.47 Million CNY | 41.92% |
| 2015 | 78.81 Million CNY | -37.39% |
| 2014 | 146.88 Million CNY | 20.07% |
| 2013 | 121.46 Million CNY | -12.08% |
| 2012 | 138 Million CNY | 0.55% |
| 2011 | 131.72 Million CNY | 15.27% |
| 2010 | 119.36 Million CNY | 43.76% |
| 2009 | 82.46 Million CNY | 25.61% |
| 2008 | 65.54 Million CNY | 27.24% |
| 2007 | 53.96 Million CNY | 27.62% |
| 2006 | 38.56 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 14.05 Million CNY | -25.14% |
| 2024 Q1 | 29.51 Million CNY | -31.58% |
| 2024 Q3 | 3.09 Million CNY | -89.52% |
| 2023 Q4 | 45.31 Million CNY | 188.83% |
| 2023 Q2 | 21.42 Million CNY | -47.26% |
| 2023 Q1 | 40.62 Million CNY | 59.55% |
| 2023 FY | - CNY | -15.18% |
| 2023 Q3 | 15.69 Million CNY | -26.75% |
| 2022 Q3 | 25.28 Million CNY | -11.3% |
| 2022 Q1 | 38.32 Million CNY | -0.71% |
| 2022 FY | - CNY | -9.87% |
| 2022 Q4 | 25.45 Million CNY | 0.69% |
| 2022 Q2 | 28.5 Million CNY | -25.61% |
| 2021 FY | - CNY | 7.08% |
| 2021 Q1 | 43.53 Million CNY | 10.7% |
| 2021 Q2 | 22.57 Million CNY | -48.14% |
| 2021 Q3 | 31.76 Million CNY | 40.69% |
| 2021 Q4 | 38.6 Million CNY | 21.52% |
| 2020 Q3 | 32.27 Million CNY | 60.11% |
| 2020 Q2 | 20.15 Million CNY | -42.83% |
| 2020 Q1 | 35.26 Million CNY | -20.29% |
| 2020 FY | - CNY | -10.79% |
| 2020 Q4 | 39.33 Million CNY | 21.87% |
| 2019 Q2 | 41.09 Million CNY | 31.58% |
| 2019 FY | - CNY | 3.91% |
| 2019 Q4 | 44.23 Million CNY | 52.76% |
| 2019 Q3 | 28.95 Million CNY | -29.53% |
| 2019 Q1 | 31.23 Million CNY | -17.76% |
| 2018 Q2 | 37.05 Million CNY | -6.12% |
| 2018 Q1 | 39.47 Million CNY | -5.52% |
| 2018 FY | - CNY | -1.89% |
| 2018 Q4 | 37.97 Million CNY | 45.1% |
| 2018 Q3 | 26.17 Million CNY | -29.38% |
| 2017 Q2 | 30.49 Million CNY | -17.4% |
| 2017 FY | - CNY | 41.63% |
| 2017 Q4 | 41.78 Million CNY | 11.09% |
| 2017 Q3 | 37.61 Million CNY | 23.33% |
| 2017 Q1 | 36.92 Million CNY | -13.94% |
| 2016 Q1 | 25.64 Million CNY | 158.16% |
| 2016 FY | - CNY | 41.92% |
| 2016 Q4 | 42.9 Million CNY | 135.82% |
| 2016 Q2 | 30.71 Million CNY | 19.76% |
| 2016 Q3 | 18.19 Million CNY | -40.76% |
| 2015 Q2 | 63.68 Million CNY | 177.99% |
| 2015 Q4 | -44.09 Million CNY | -270.02% |
| 2015 Q3 | 25.93 Million CNY | -59.28% |
| 2015 FY | - CNY | -37.39% |
| 2015 Q1 | 22.9 Million CNY | -49.31% |
| 2014 Q1 | 19.94 Million CNY | -48.92% |
| 2014 Q2 | 44.56 Million CNY | 123.42% |
| 2014 Q4 | 45.19 Million CNY | 66.58% |
| 2014 FY | - CNY | 20.07% |
| 2014 Q3 | 27.12 Million CNY | -39.13% |
| 2013 Q1 | 15.61 Million CNY | -73.34% |
| 2013 Q2 | 41.38 Million CNY | 164.99% |
| 2013 Q3 | 21.38 Million CNY | -48.33% |
| 2013 Q4 | 39.05 Million CNY | 82.62% |
| 2013 FY | - CNY | -12.08% |
| 2012 FY | - CNY | 0.55% |
| 2012 Q4 | 58.58 Million CNY | 204.89% |
| 2012 Q2 | 28.45 Million CNY | 161.46% |
| 2012 Q3 | 19.21 Million CNY | -32.49% |
| 2012 Q1 | 10.88 Million CNY | -78.84% |
| 2011 Q3 | 19.93 Million CNY | -36.64% |
| 2011 FY | - CNY | 15.27% |
| 2011 Q4 | 51.44 Million CNY | 158.13% |
| 2011 Q1 | 20.89 Million CNY | -50.72% |
| 2011 Q2 | 31.45 Million CNY | 50.53% |
| 2010 Q3 | 26.39 Million CNY | 45.07% |
| 2010 Q2 | 18.19 Million CNY | 4.96% |
| 2010 FY | - CNY | 43.76% |
| 2010 Q1 | 17.33 Million CNY | 0.0% |
| 2010 Q4 | 42.4 Million CNY | 60.7% |
| 2009 FY | - CNY | 25.61% |
| 2008 FY | - CNY | 27.24% |
| 2007 FY | - CNY | 27.62% |
| 2006 FY | - CNY | 0.0% |